Login to Your Account



Vitamin A derivative selectively kills liver cancer stem cells

By John Fox
Staff Writer

Friday, April 27, 2018

HONG KONG – An artificial compound derived from vitamin A, acyclic retinoid (ACR), has been shown to selectively target cancer stem cells (CSCs) and reduce the post-therapeutic recurrence of hepatocellular carcinoma (HCC) in a new study and is currently in phase III trials for that indication in Asia.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription